GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » DeferredTaxAndRevenue

Curatis Holding AG (CHIX:CURNZ) DeferredTaxAndRevenue : CHF0.00 Mil (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Curatis Holding AG's current deferred tax and revenue for the quarter that ended in Jun. 2024 was CHF0.00 Mil.

Curatis Holding AG DeferredTaxAndRevenue Historical Data

The historical data trend for Curatis Holding AG's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG DeferredTaxAndRevenue Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
DeferredTaxAndRevenue
- - -

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
DeferredTaxAndRevenue Get a 7-Day Free Trial - - - - -

Curatis Holding AG DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Curatis Holding AG Business Description

Traded in Other Exchanges
Address
Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.

Curatis Holding AG Headlines

No Headlines